Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow Print PDF (205K) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (8)
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Miner, Z.
Right arrow Articles by Kulesz-Martin, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Miner, Z.
Right arrow Articles by Kulesz-Martin, M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nucleic Acids Research, Vol 25, Issue 7 1319-1326, Copyright © 1997 by Oxford University Press

ARTICLES

DNA binding specificity of proteins derived from alternatively spliced mouse p53 mRNAs

Z Miner and M Kulesz-Martin
Roswell Park Cancer Institute, Department of Experimental Therapeutics, GCDC Room 403, Elm and Carlton Streets, Buffalo, NY 14263, USA.

The mouse p53 gene generates two alternative splice products encoding p53 protein and a naturally occurring protein (p53as) with changes at the C-terminus. In p53as the negative regulatory region for DNA binding and PAb421 antibody binding site are replaced, and p53as is constitutively active for sequence-specific DNA binding. Using the technique of randomized synthetic oligonucleotide in cyclic amplification and selection of targets, we have found that p53as and p53 proteins have the same DNA binding specificities but that these specificities frequently diverge from the consensus of two copies of PuPuPuCATGPyPyPy. The importance of tetranucleotide CATG was confirmed but there was a less rigorous requirement for patterns of flanking or intervening sequences. In particular, the three purines upstream and three pyrimidines downstream of CATG are not required for p53 or p53as binding, 29 or more intervening nucleotides are tolerated, and one CATG is sufficient where adjacent nucleotides contain a region of homology with certain previously reported non-consensus p53 binding sequences. These results suggested further definition of the non-consensus motifs, and database searches with these uncovered additional candidate genes for p53 protein binding. We conclude that p53as and perhaps other activated forms of p53 exert their effects on the same genes and that differential activities of p53 protein forms are not due to inherently different sequence selectivities of DNA binding.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 RNAHome page
K. J.-L. RILEY, L. A. CASSIDAY, A. KUMAR, and L. J. MAHER III
Recognition of RNA by the p53 tumor suppressor protein in the yeast three-hybrid system.
RNA, April 1, 2006; 12(4): 620 - 630.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
N. Almog, M. Milyavsky, P. Stambolsky, A. Falcovitz, N. Goldfinger, and V. Rotter
The role of the C' terminus of murine p53 in the p53/mdm-2 regulatory loop
Carcinogenesis, May 1, 2001; 22(5): 779 - 785.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
Y. Wu, H. Huang, Z. Miner, and M. Kulesz-Martin
Activities and response to DNA damage of latent and active sequence-specific DNA binding forms of mouse p53
PNAS, August 19, 1997; 94(17): 8982 - 8987.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.